article thumbnail

Almost 50% of Patients Under 60 Years Choose TAVR Over Surgical Aortic Valve Replacement with Worse Outcomes

DAIC

From a pool of 37,011 patients, the study identified 2,360 patients under the age of 60 years who underwent these procedures, with 22% receiving TAVR and 78% SAVR. By 2021 almost half of patients younger than 60 years were receiving TAVR rather than SAVR. years after TAVR and 4.9 years after TAVR and 4.9

article thumbnail

TAVR in Young Patients With Aortic Stenosis

JAMA Cardiology

American College of Cardiology/American Heart Association guideline recommendations for transcatheter aortic valve replacement (TAVR) transitioned in 2020 from decision-making based on estimated risk of surgical valve replacement (SAVR) to one based on patient age and expected longevity.

TAVR 40
article thumbnail

Drivers and outcomes of variation in surgical versus transcatheter aortic valve replacement in Ontario, Canada: a population-based study

Open Heart

Objectives To understand the patient and hospital level drivers of the variation in surgical versus trascatheter aortic valve replacement (SAVR vs TAVR) for patients with aortic stenosis (AS) and to explore whether this variation translates into differences in clinical outcomes. Background Adoption of TAVR has grown exponentially worldwide.

article thumbnail

FDA Advisory Committee Votes in Favor of Abbott’s First-of-its-kind Triclip System to Treat People with a Leaky Tricuspid Heart Valve

DAIC

Advances in Transcatheter Tricuspid Valve Technologies VIDEO: Tricuspid Device Clinical Trial Overview — Interview with Ori Ben-Yehuda, M.D.

Tricuspid 102
article thumbnail

Concomitant Left Atrial Appendage Occlusion and Transcatheter Aortic Valve Replacement Among Patients with Atrial Fibrillation

Circulation

Background: Atrial fibrillation (AF) is common in patients undergoing transcatheter aortic valve replacement (TAVR) and is associated with increased risk of bleeding and stroke. Patients were randomized 1:1 to TAVR+LAAO or TAVR+medical therapy. For the composite primary endpoint, TAVR+.LAAO and HAS-BLED score was 3.0.

article thumbnail

Cardiology AI Clearances Growing, Diversifying

CardiacWire

Cardiovascular AI’s total share of H1 2024 AI clearances was the highest since 2020 (both 18%), after landing between 14% and 16% during the last three years. FFRCT, coronary plaque, echo AI, etc)… We’re using this broader definition of cardio AI through the rest of this story.

article thumbnail

American College of Cardiology ACC.24 Late-breaking Science and Guidelines Session Summary

DAIC

24: Joint American College of Cardiology/Journal of the American College of Cardiology Late-Breaking Clinical Trials (Session 402) Saturday, April 6 9:30 – 10:30 a.m. ET Murphy Ballroom 4 ACC.24 24 planners note that attendees can gain insights from key clinical trials presented at ACC.24